June 23, 2025
Authored and Edited by Christopher B. Anderson; Sonja W. Sahlsten; Jack McLaughlan*
In Regents of the Univ. of Cal. v. Broad Inst., Inc., No. 2022-1594 (Fed. Cir. May 12, 2025), the Federal Circuit vacated in part a determination by the Patent Trial and Appeal Board in a patent interference proceeding, ruling that the Board incorrectly applied the legal standard for conception.
Both The Regents of the University of California (“Regents”), and The Broad Institute (“Broad”) asserted priority of invention for patent claims relating to CRISPR-Cas9 Systems that contain a “single guide” RNA that edits or cleaves DNA in eukaryotic cells.
The Board awarded Broad priority based on an October 5, 2012, publication after rejecting Regents’ earliest asserted conception date of March 1, 2012, and reduction to practice date of August 9, 2012, based on Regents’ statements of uncertainty about whether its experiments would translate to human cells.
On appeal, the Federal Circuit vacated the Board’s decision regarding conception. It concluded that the Board conflated conception and reduction to practice by improperly focusing on Regents’ statements of uncertainty and requiring Regents’ scientists to know their invention would work to prove conception. As the Federal Circuit clarified, knowledge that an invention will work is relevant not to conception, but to reduction to practice. The Board also erred by focusing on Regents’ expressions of doubt regarding their experimental success. Instead, the conception analysis must turn on whether Regents’ scientists had formed the idea in a final form such that only the application of ordinary skill in the art was needed to reduce it to practice. The Court separately affirmed the Board’s analysis regarding written description support and denied Broad’s cross-appeal on claim construction as moot.
*Jack McLaughlan is a Summer Associate at Finnegan.
Copyright © Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.